Uncategorized
Ocata Therapeutics to Present at the Cantor Fitzgerald Inaugural Healthcare Conference
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that Paul Wotton, Ph.D., President and Chief Executive Officer, will present a company overview at the Cantor Fitzgerald Inaugural Healthcare Conference on Wednesday, July 8, 2015 at 11:15 a.m. EDT at the Le Parker Meridien Hotel, New York City. A live audio webcast of the presentation will be available via the "Investor Re
